Medical Writing Artificial intelligence and Digital Health Drug development and medical writing in the digital world

Volume 28, Issue 4 - Artificial intelligence and Digital Health

Drug development and medical writing in the digital world

Abstract

Artificial intelligence and digital health open a new chapter in the pharmaceutical industry. The digital technologies improve work efficiency, lower research and development costs, optimise medical research processes, and increase R&D outputs. The digital revo - lution had a significant impact on almost every aspect of drug development from preclinical to clinical studies with digital end - points and post-market surveillance of safety events, and even for medical education. In the area of medical writing, digital technologies led to the transparency of medical research and close scientific communications in the paperless systems and offered more possi - bilities for scientific collaborations between study sponsors and clinical practitioners. The writing styles and publishing media became more diverse along with the use of mobile health apps. In parallel, new technologies also offer wider career pathways; therefore, writing professionals with multiple skills are needed in the digital world.

Download the full article

References

  1. Tianle Shen and Xiaolong Fu. Application and prospect of artificial intelligence in cancer diagnosis and treatment. Chin J Oncol. 2018;40(12):881-4.
  2. National Academies of Sciences, Engineer - ing, and Medicine et al. Proceedings of a workshop – in brief. Artificial intelligence and machine learning to accelerate translational research. 2018 Jul [cited 2019 Jun 29]. Available from: https://www.nap.edu/read/ 25197/chapter/1#
  3. Sellwood MA, Ahmed M, Segler MH, Brown N. Artificial intelligence in drug discovery. Future Med Chem. 2018 Sep;10(17):2025–8.
  4. Liu JF, Lee JM, Strock E, Phillips R, et al. Technology applications: use of digital health technology to enable drug development. JCO Clin Cancer Inform. 2018 Dec;2(2):1–12.
  5. Daemmrich A, Mohanty A. Healthcare reform in the United States and China: pharmaceutical market implications. J Pharm Policy Pract. 2014 Jul;7(1):9.
  6. Deloitte: A new future for R&D? Measuring the return from pharmaceutical innovation 2017.
  7. Lodrini M, Sprussel A, Astrahantseff K, et al. Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget. 2107;8(49):85234-51.
  8. Boehme P, Hansen A, Roubenoff R, et al. How soon will digital endpoints become a cornerstone for future drug development? Drug Discov Today. 2019 Jan;24(1):16–9.
  9. Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people – results from the Health, Ageing and Body Composition Study. J Am Geriatr Soc. 2005 Oct;53(10):1675–80.
  10. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011 Jan;305(1):50–8.
  11. Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3Dprinted drug products. Adv Drug Deliv Rev. 2017 Jan;108:39–50.
  12. Pear Therapeutics: FDA launched a first digital treatment regimen that redefines medications. 2018 Jul [cited 2019 Jun 29]. Available from: http://www.sohu.com/a/241824883 _133140.
  13. www.360doc.comThe importance of digital health in the healthcare sector of listed companies. 2017 Jan [cited 2019 Jul 3]. Available from: http://www.360doc.com/content/ 17/0104/13/36864145_619985235. shtml.
  14. Baidu database. Weekly updates on the industry of biomedicine and digital health. 2019 Mar [cited 2019 Jul 3]. Available from: https://wenku.baidu.com/view/ 6359d994b42acfc789eb172ded630b1c58e e9b62.html
  15. Sohu Healthcare. How do pharmaceutical companies to offer add-value services in addition to drugs? Perspectives from digital health. 2017 Mar [cited 2019 Jul 3]. Available from: http://www.sohu.com/a/128247051_ 456032
  16. Housman LT. “I’m Home (screen)!”: social media in health care has arrived. Clin Ther. 2017 Nov;39(11):2189–95.
  17. How to offer add-value services in pharmaceutical companies? Talking from digital health. 2017 Mar [cited 2019 Jun 29]. Available from: http://www.sohu.com/a/ 128247051_456032
  18. Satre DD, Ly K, Wamsley M, Curtis A, Satterfield J. A digital tool to promote alcohol and drug use screening, brief intervention, and referral to treatment skill translation: a mobile App development and randomized controlled trial protocol. JMIR Res Protoc. 2017 Apr;6(4):e55.
  19. Dijkstra NE, Sino CG, Heerdink ER, Schuurmans MJ. Development of eHOME, a mobile instrument for reporting, monitoring, and consulting drug-related problems in home care: human-centered design study. JMIR Human Factors. 2018 Mar;5(1):e10.
  20. Metcalf CS, Huntsman M, Garcia G, et al. Music-enhanced analgesia and antiseizure activities in animal models of pain and epilepsy: toward preclinical studies supp - orting development of digital therapeutics and their combinations with pharmaceutical drugs. J Front Neurol. 2019;10:277.

Search

Articles

Table of Contents
Artificial intelligence and digital health
President's Message
EMWA News
Medical writing in the era of artificial intelligence
Blockchain in healthcare, research, and scientific publishing
Embracing a new friendship: Artificial intelligence and medical writers
Drug development and medical writing in the digital world
Intelligent use of artificial intelligence for systematic reviews of medical devices
What medical writers need to know about regulatory approval of mobile health and digital healthcare devices
Digitalisation in long-term care: An issue for medical writers?
An introduction to medical affairs for medical writers
A primer on anonymisation
Sound, microphone, action: Podcasts for medical writers
Regulatory Matters
News from the EMA
Lingua Franca and Beyond
In the Bookstores
Getting Your Foot in the Door
Medical Devices
Veterinary Medical Writing
Teaching Medical Writing
Journal Watch
Medical Communications and Writing for Patients
Good Writing Practice
Out on Our Own
Upcoming issues of Medical Writing

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Clare Chang

Barbara Grossman

Daniela Nakagawa

Joselita T. Salita

Petal Smart

Amy Whereat

Section Editors

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News       

Aurélie Gobet / Paolo Rega

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh / Stephen Gilliver

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Phil Leventhal

Manuscript Writing

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Namrata Upadhyay

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Laura Kehoe

Out on Our Own

Tiziana von Bruchhausen

Pharmacovigilance

Jennifer Morris

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Kimi Uegaki

The Crofter: Sustainable Communications

Jennifer Bell / Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Lay out Designer

Chris Monk